IBDEI04E ; ; 18-FEB-2009
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 18, 2009
 Q:'DIFQR(358.3)  F I=3D1:2 S X=3D$T(Q+I) Q:X=3D""  S
Y=3D$E($T(Q+I+1),4,999),X=3D$E(X,4,999) S:$A(Y)=3D126
I=3DI+1,Y=3D$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=3D61 Y=3D$E(Y,2,999) =
X NO E
S @X=3DY
Q Q
 ;;^UTILITY(U,$J,358.3,4499,1,4,0)
 ;;=3D4^V17.3
 ;;^UTILITY(U,$J,358.3,4499,1,5,0)
 ;;=3D5^Family H/O Ischemic Heart Dis
 ;;^UTILITY(U,$J,358.3,4499,2)
 ;;=3D^295305
 ;;^UTILITY(U,$J,358.3,4500,0)
 ;;=3DV16.6^^42^339^19
 ;;^UTILITY(U,$J,358.3,4500,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4500,1,4,0)
 ;;=3D4^V16.6
 ;;^UTILITY(U,$J,358.3,4500,1,5,0)
 ;;=3D5^Family H/O Leukemia
 ;;^UTILITY(U,$J,358.3,4500,2)
 ;;=3D^295298
 ;;^UTILITY(U,$J,358.3,4501,0)
 ;;=3DV18.61^^42^339^21
 ;;^UTILITY(U,$J,358.3,4501,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4501,1,4,0)
 ;;=3D4^V18.61
 ;;^UTILITY(U,$J,358.3,4501,1,5,0)
 ;;=3D5^Family H/O Polycystic Kidney
 ;;^UTILITY(U,$J,358.3,4501,2)
 ;;=3D^321531
 ;;^UTILITY(U,$J,358.3,4502,0)
 ;;=3DV17.0^^42^339^22
 ;;^UTILITY(U,$J,358.3,4502,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4502,1,4,0)
 ;;=3D4^V17.0
 ;;^UTILITY(U,$J,358.3,4502,1,5,0)
 ;;=3D5^Family H/O Psychiatric Condition
 ;;^UTILITY(U,$J,358.3,4502,2)
 ;;=3D^295302
 ;;^UTILITY(U,$J,358.3,4503,0)
 ;;=3DV19.4^^42^339^23
 ;;^UTILITY(U,$J,358.3,4503,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4503,1,4,0)
 ;;=3D4^V19.4
 ;;^UTILITY(U,$J,358.3,4503,1,5,0)
 ;;=3D5^Family H/O Skin Condition
 ;;^UTILITY(U,$J,358.3,4503,2)
 ;;=3D^295324
 ;;^UTILITY(U,$J,358.3,4504,0)
 ;;=3DV17.1^^42^339^24
 ;;^UTILITY(U,$J,358.3,4504,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4504,1,4,0)
 ;;=3D4^V17.1
 ;;^UTILITY(U,$J,358.3,4504,1,5,0)
 ;;=3D5^Family H/O Stroke (Cerebrovascular)
 ;;^UTILITY(U,$J,358.3,4504,2)
 ;;=3D^295303
 ;;^UTILITY(U,$J,358.3,4505,0)
 ;;=3DV16.8^^42^339^20
 ;;^UTILITY(U,$J,358.3,4505,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4505,1,4,0)
 ;;=3D4^V16.8
 ;;^UTILITY(U,$J,358.3,4505,1,5,0)
 ;;=3D5^Family H/O Other Specified Cancer
 ;;^UTILITY(U,$J,358.3,4505,2)
 ;;=3D^295300
 ;;^UTILITY(U,$J,358.3,4506,0)
 ;;=3DV11.1^^42^339^47
 ;;^UTILITY(U,$J,358.3,4506,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4506,1,4,0)
 ;;=3D4^V11.1
 ;;^UTILITY(U,$J,358.3,4506,1,5,0)
 ;;=3D5^Personal H/O Affective Disorder
 ;;^UTILITY(U,$J,358.3,4506,2)
 ;;=3D^295250
 ;;^UTILITY(U,$J,358.3,4507,0)
 ;;=3DV15.89^^42^339^55
 ;;^UTILITY(U,$J,358.3,4507,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4507,1,4,0)
 ;;=3D4^V15.89
 ;;^UTILITY(U,$J,358.3,4507,1,5,0)
 ;;=3D5^Personal H/O Exposure To Persian Gulf Region
 ;;^UTILITY(U,$J,358.3,4507,2)
 ;;=3D^295291
 ;;^UTILITY(U,$J,358.3,4508,0)
 ;;=3DV11.3^^42^339^48
 ;;^UTILITY(U,$J,358.3,4508,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4508,1,4,0)
 ;;=3D4^V11.3
 ;;^UTILITY(U,$J,358.3,4508,1,5,0)
 ;;=3D5^Personal H/O Alcoholism
 ;;^UTILITY(U,$J,358.3,4508,2)
 ;;=3D^295252
 ;;^UTILITY(U,$J,358.3,4509,0)
 ;;=3DV15.07^^42^339^49
 ;;^UTILITY(U,$J,358.3,4509,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4509,1,4,0)
 ;;=3D4^V15.07
 ;;^UTILITY(U,$J,358.3,4509,1,5,0)
 ;;=3D5^Personal H/O Allerlgy To Latex
 ;;^UTILITY(U,$J,358.3,4509,2)
 ;;=3D^322043
 ;;^UTILITY(U,$J,358.3,4510,0)
 ;;=3DV13.4^^42^339^50
 ;;^UTILITY(U,$J,358.3,4510,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4510,1,4,0)
 ;;=3D4^V13.4
 ;;^UTILITY(U,$J,358.3,4510,1,5,0)
 ;;=3D5^Personal H/O Arthritis
 ;;^UTILITY(U,$J,358.3,4510,2)
 ;;=3D^295267
 ;;^UTILITY(U,$J,358.3,4511,0)
 ;;=3DV12.72^^42^339^51
 ;;^UTILITY(U,$J,358.3,4511,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4511,1,4,0)
 ;;=3D4^V12.72
 ;;^UTILITY(U,$J,358.3,4511,1,5,0)
 ;;=3D5^Personal H/O Colon Polyps
 ;;^UTILITY(U,$J,358.3,4511,2)
 ;;=3D^303401
 ;;^UTILITY(U,$J,358.3,4512,0)
 ;;=3DV12.59^^42^339^52
 ;;^UTILITY(U,$J,358.3,4512,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4512,1,4,0)
 ;;=3D4^V12.59
 ;;^UTILITY(U,$J,358.3,4512,1,5,0)
 ;;=3D5^Personal H/O Congestive Heart Failure
 ;;^UTILITY(U,$J,358.3,4512,2)
 ;;=3D^303399
 ;;^UTILITY(U,$J,358.3,4513,0)
 ;;=3DV45.81^^42^339^53
 ;;^UTILITY(U,$J,358.3,4513,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4513,1,4,0)
 ;;=3D4^V45.81
 ;;^UTILITY(U,$J,358.3,4513,1,5,0)
 ;;=3D5^Personal H/O Coronary Bypass
 ;;^UTILITY(U,$J,358.3,4513,2)
 ;;=3D^97129
 ;;^UTILITY(U,$J,358.3,4514,0)
 ;;=3DV15.84^^42^339^54
 ;;^UTILITY(U,$J,358.3,4514,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4514,1,4,0)
 ;;=3D4^V15.84
 ;;^UTILITY(U,$J,358.3,4514,1,5,0)
 ;;=3D5^Personal H/O Exposure To Asbestos
 ;;^UTILITY(U,$J,358.3,4514,2)
 ;;=3D^303406
 ;;^UTILITY(U,$J,358.3,4515,0)
 ;;=3DV15.85^^42^339^58
 ;;^UTILITY(U,$J,358.3,4515,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4515,1,4,0)
 ;;=3D4^V15.85
 ;;^UTILITY(U,$J,358.3,4515,1,5,0)
 ;;=3D5^Personal H/O Potentially Hazardous Body Fluids
 ;;^UTILITY(U,$J,358.3,4515,2)
 ;;=3D^303407
 ;;^UTILITY(U,$J,358.3,4516,0)
 ;;=3DV10.72^^42^339^56
 ;;^UTILITY(U,$J,358.3,4516,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4516,1,4,0)
 ;;=3D4^V10.72
 ;;^UTILITY(U,$J,358.3,4516,1,5,0)
 ;;=3D5^Personal H/O Hodgkin'S Disease
 ;;^UTILITY(U,$J,358.3,4516,2)
 ;;=3D^295237
 ;;^UTILITY(U,$J,358.3,4517,0)
 ;;=3DV15.3^^42^339^57
 ;;^UTILITY(U,$J,358.3,4517,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4517,1,4,0)
 ;;=3D4^V15.3
 ;;^UTILITY(U,$J,358.3,4517,1,5,0)
 ;;=3D5^Personal H/O Irradiation
 ;;^UTILITY(U,$J,358.3,4517,2)
 ;;=3D^295285
 ;;^UTILITY(U,$J,358.3,4518,0)
 ;;=3DV10.61^^42^339^32
 ;;^UTILITY(U,$J,358.3,4518,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4518,1,4,0)
 ;;=3D4^V10.61
 ;;^UTILITY(U,$J,358.3,4518,1,5,0)
 ;;=3D5^Hx Of Lymphoid Leukemia
 ;;^UTILITY(U,$J,358.3,4518,2)
 ;;=3DHx of Lymphoid Leukemia^295232
 ;;^UTILITY(U,$J,358.3,4519,0)
 ;;=3DV12.03^^42^339^33
 ;;^UTILITY(U,$J,358.3,4519,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4519,1,4,0)
 ;;=3D4^V12.03
 ;;^UTILITY(U,$J,358.3,4519,1,5,0)
 ;;=3D5^Hx Of Malaria
 ;;^UTILITY(U,$J,358.3,4519,2)
 ;;=3DHx of Malaria^303395
 ;;^UTILITY(U,$J,358.3,4520,0)
 ;;=3DV10.82^^42^339^34
 ;;^UTILITY(U,$J,358.3,4520,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4520,1,4,0)
 ;;=3D4^V10.82
 ;;^UTILITY(U,$J,358.3,4520,1,5,0)
 ;;=3D5^Hx Of Malignant Melanoma
 ;;^UTILITY(U,$J,358.3,4520,2)
 ;;=3DHx of Malignant Melanoma^295240
 ;;^UTILITY(U,$J,358.3,4521,0)
 ;;=3DV10.62^^42^339^36
 ;;^UTILITY(U,$J,358.3,4521,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4521,1,4,0)
 ;;=3D4^V10.62
 ;;^UTILITY(U,$J,358.3,4521,1,5,0)
 ;;=3D5^Hx Of Myeloid Leukemia
 ;;^UTILITY(U,$J,358.3,4521,2)
 ;;=3DHx of Myeloid Leukemia^295233
 ;;^UTILITY(U,$J,358.3,4522,0)
 ;;=3DV10.63^^42^339^35
 ;;^UTILITY(U,$J,358.3,4522,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4522,1,4,0)
 ;;=3D4^V10.63
 ;;^UTILITY(U,$J,358.3,4522,1,5,0)
 ;;=3D5^Hx Of Monocytic Leukemia
 ;;^UTILITY(U,$J,358.3,4522,2)
 ;;=3DHx of Monocytic Leukemia^295234
 ;;^UTILITY(U,$J,358.3,4523,0)
 ;;=3DV11.2^^42^339^30
 ;;^UTILITY(U,$J,358.3,4523,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4523,1,4,0)
 ;;=3D4^V11.2
 ;;^UTILITY(U,$J,358.3,4523,1,5,0)
 ;;=3D5^Hx Of Dysthymia
 ;;^UTILITY(U,$J,358.3,4523,2)
 ;;=3DHx of Dysthymia^295251
 ;;^UTILITY(U,$J,358.3,4524,0)
 ;;=3DV15.81^^42^339^46
 ;;^UTILITY(U,$J,358.3,4524,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4524,1,4,0)
 ;;=3D4^V15.81
 ;;^UTILITY(U,$J,358.3,4524,1,5,0)
 ;;=3D5^Noncompliance With Medical Treatment
 ;;^UTILITY(U,$J,358.3,4524,2)
 ;;=3D^295290
 ;;^UTILITY(U,$J,358.3,4525,0)
 ;;=3DV10.43^^42^339^37
 ;;^UTILITY(U,$J,358.3,4525,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4525,1,4,0)
 ;;=3D4^V10.43
 ;;^UTILITY(U,$J,358.3,4525,1,5,0)
 ;;=3D5^Hx Of Ovarian Ca
 ;;^UTILITY(U,$J,358.3,4525,2)
 ;;=3DHx of Ovarian CA^295221
 ;;^UTILITY(U,$J,358.3,4526,0)
 ;;=3DV12.71^^42^339^38
 ;;^UTILITY(U,$J,358.3,4526,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4526,1,4,0)
 ;;=3D4^V12.71
 ;;^UTILITY(U,$J,358.3,4526,1,5,0)
 ;;=3D5^Hx Of Peptic Ulcer Disease
 ;;^UTILITY(U,$J,358.3,4526,2)
 ;;=3D^303400
 ;;^UTILITY(U,$J,358.3,4527,0)
 ;;=3DV10.46^^42^339^39
 ;;^UTILITY(U,$J,358.3,4527,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4527,1,4,0)
 ;;=3D4^V10.46
 ;;^UTILITY(U,$J,358.3,4527,1,5,0)
 ;;=3D5^Hx Of Prostate Cancer
 ;;^UTILITY(U,$J,358.3,4527,2)
 ;;=3DHx of Prostate Cancer^295224
 ;;^UTILITY(U,$J,358.3,4528,0)
 ;;=3DV11.0^^42^339^40
